Table 2 Health outcomes in the treat-to-target (T2T) and usual care (UC) groups after two and three years of follow-up
Two years | Three years | |||||
|---|---|---|---|---|---|---|
T2T (n=261) | UC (n=213) | UC from 2006 (n=69) | T2T (n=127) | UC (n=180) | UC from 2006 (n=45) | |
DAS28, mean ± SD | 2.4 ± 1.0 | 3.1 ± 1.3† | 2.8 ± 1.1† | 2.5 ± 1.0 | 3.1 ± 1.3† | 2.7 ± 1.1 |
DAS28 level, n (%) | ||||||
Remission (DAS28 < 2.6) | 168 (64.4) | 74 (34.7)† | 33 (47.8)† | 76 (59.8) | 63 (35.0)† | 25 (55.6) |
Low (2.6 ≤ DAS28 ≤ 3.2) | 48 (18.4) | 44 (20.7) | 14 (20.3) | 28 (22.0) | 35 (19.4) | 5 (11.1) |
Moderate (3.2 < DAS28 ≤ 5.1) | 37 (14.2) | 76 (35.7)† | 19 (27.5)† | 21 (16.5) | 72 (40.0)† | 14 (31.1)† |
High (DAS28 > 5.1) | 8 (3.1) | 19 (8.9)† | 3 (4.3) | 2 (1.6) | 10 (5.6) | 1 (2.2) |
QALYs, median (IQR) | 1.45 (1.24-1.55) (n=221) | 1.39 (1.18-1.53) (n=143)† | 1.44 (1.21-1.55) (n=47) | 2.19 (1.81-2.34) (n=101) | 2.04 (1.64-2.27) (n=106)† | 1.95 (1.50-2.34) (n=18) |